丹红注射液对急性心肌梗死并发症影响临床观察

Clinical Effects of Danhong Injecta on complications of Acute Myocardial Infarction

目的:探讨丹红注射液对急性心肌梗死并发症发生的影响及机制。方法:120例急性心肌梗死患者随机分为对照组和治疗组,两组给予相同的吸氧,扩冠,抗凝,溶栓,镇静等基础治疗,治疗组给予丹红注射液30 mL/d,观察两组患者治疗2周后的心肌酶谱变化情况,并发症发生率及死亡率。结果:治疗组2周后心肌酶回降幅度大于对照组,并发症发生率低于对照组,死亡率与对照组无显著差异。结论:丹红注射液能减少心肌梗死患者并发症发生,改善心肌梗死病人预后,具有较好的临床治疗效果。

Objective：To observe effects of danhong injecta on complications of acute myocardial （AMI） infarction and investigate its reasons. Methods： Sixscore patients with AMI were divided into control group（CG） and experimental group （EG）. All patients recive identifical ba -sal treatment. The patients in （EG） received a total of 30ml/d of danhong injecta, change of enzymology in cardiac muscle and percentage of complications were obeserve in 14th, death rate was obeserve too. Results： In comparetion with CG on 14th,the change of enzymology in cardiac muscle is more,the percentage of complications was lesser, and death rate was indistinctive in EG. Conclusions： Danhong injecta can decreasing compations of AMI, improve prognosis, and reseive a good therapeutic efficacy.